Long-term study of HP-3150 in patients with cancer pain.
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2016
At a glance
- Drugs HP 3150 (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 30 Nov 2016 Status changed from recruiting to completed.
- 08 Jun 2016 New trial record